Addiction stigma means negative attitudes and stereotypes that can affect how people are treated, how they see themselves, and whether they seek care. Respectful language matters, but reducing stigma also requires attention to biased healthcare decisions, misconceptions about treatment, and barriers that words alone cannot remove.
You or someone you love may recognize stigma through shame about seeking addiction treatment or fear of judgment when considering care. Those feelings are part of a broader issue. Stigma can appear in an everyday label, an assumption about someone's character, or a decision that limits access to treatment. Understanding these differences helps separate a person's health needs from stereotypes about substance use. It also leaves room for accountability, personal preferences, and realistic expectations. No single word choice can guarantee respectful care, and no diagnosis tells the whole story of a person's life.
Written by Tim Francis, SUD Content Specialist.
Tim is a nonclinical author. This guide supports discussion with qualified professionals.
What is addiction stigma, and how does it differ from discrimination?
Addiction stigma means negative attitudes and stereotypes about substance use or substance use disorders. Discrimination occurs when those judgments shape unequal treatment. Experiences of shame about seeking treatment and fear of judgment may reflect that wider problem, which can operate through personal interactions, healthcare decisions, and public policy.
The National Institute on Drug Abuse's explanation of stigma and discrimination describes substance use disorders as chronic, treatable medical conditions. Yet people may still be seen as untrustworthy, dangerous, or personally to blame. A stereotype makes an assumption about a group. Discrimination puts a judgment into practice, such as when bias contributes to withholding appropriate healthcare.
Stigma can take several connected forms:
- Public stigma: negative beliefs held by other people.
- Self-stigma: negative beliefs someone applies to themselves.
- Healthcare bias: stereotypes influencing assessment or treatment.
- Systemic barriers: policies or practices shaped by stigmatizing assumptions.
These distinctions matter because the response must match the problem. Replacing an insulting label addresses language. It does not, by itself, correct a biased treatment decision. Stigma can also affect people who use drugs without having a substance use disorder. Substance use alone should not become an assumed diagnosis or a judgment about someone's character.
Why does treating addiction as a moral failure misrepresent the condition?
Addiction involves impaired control, not a simple lack of character. Changes in reward, stress, and decision-making can make stopping difficult despite serious consequences. Recognizing that condition allows healthy personal boundaries and structured recovery treatment to coexist: a person can need help while remaining responsible for addressing specific harmful behavior.
According to NIDA's account of drugs and the brain, repeated drug exposure can alter circuits involved in reinforcement, stress, and self-control. Drug-related signals can gain strong motivational importance, while other activities become less rewarding. These changes help explain why continued use can occur even when a person recognizes the costs. They do not mean that every person has identical brain changes or that recovery is impossible.
Genetic and social factors also influence vulnerability, as NIDA explains in its stigma research overview. Reducing addiction to a moral failure leaves those factors out. Reducing a person to brain changes would also leave out their relationships, circumstances, values, and capacity for change.
For example, naming a broken agreement describes an event that needs attention. Declaring someone permanently dishonest turns an event into a fixed identity. The first leaves room for repair and boundaries; the second treats change as irrelevant.
How can language reinforce or reduce addiction stigma?
Language can reinforce addiction stigma when it turns a health condition into someone's whole identity or implies blame. Describing the person, behavior, or clinical finding precisely is more useful. This matters in discussions of treatment-related shame and fear of being judged, while leaving room for each person's chosen self-description.
This is more than a preference for polite wording. NIDA summarizes research showing that labels can influence clinicians' attitudes. In one study, clinicians viewed a person described as a “substance abuser” as more deserving of blame and punishment than someone described as “having a substance use disorder.” That finding concerns an effect on judgment, not a guarantee that changing one term changes all care.
| Wording to reconsider | More precise alternative | Why the distinction matters |
|---|---|---|
| “An addict” as an imposed label | “A person with a substance use disorder” | Names a condition without making it the person's entire identity. |
| “A substance abuser” | “A person with a substance use disorder,” when diagnosed | Avoids a label associated with blame and punishment. |
| Assuming anyone who uses drugs has addiction | “A person who uses drugs,” when that is what is known | Separates substance use from an established medical diagnosis. |
| “Dirty” or “clean” to describe a test | Describe what the test detected or did not detect | Reports a finding without implying personal contamination or purity. |
| “Treatment failed” after renewed use | “A return to use” or “a recurrence” | Describes what happened without deciding that further treatment is pointless. |
These are editorial examples of more specific wording, not rules for correcting someone's chosen identity. NIDA recognizes that people in recovery may use different terms for themselves, particularly in recovery groups. Respecting that choice differs from assigning the same label to another person.
Person-first language is a useful default in public information and healthcare. It should make communication clearer, not become another way to judge who is describing recovery correctly.
How does self-stigma differ from other people's judgment?
Self-stigma develops when someone absorbs negative beliefs about substance use and applies them to themselves. Other people's judgment comes from outside; self-stigma turns that judgment into a verdict about personal worth. Shame about getting help can overlap with this process, while peer support and therapy provide different forms of support.
A concern about a specific action is different from believing that you are inherently undeserving of care. The distinction is between “something happened that needs to change” and “I am beyond help.” These examples illustrate different meanings; they are not a diagnosis of how any particular person thinks.
NIDA notes that self-stigma, shame, and isolation may reinforce drug-seeking behavior. The relationship is not inevitable, and feeling ashamed does not mean a person will return to use. It does show why adding humiliation to an already difficult condition can work against care rather than motivate it.
Self-stigma also does not prove that someone has actually been rejected in every setting. It can reflect past mistreatment, repeated social messages, or anticipated judgment. At the same time, treating it only as a private thinking problem would overlook the real discrimination that may have helped create it.
How can addiction stigma affect disclosure and healthcare?
Addiction stigma can make people fear judgment when disclosing substance use or feel ashamed about seeking treatment. That can delay healthcare or leave clinicians without information relevant to care. Stigma also operates after disclosure, when stereotypes influence how symptoms, treatment needs, or the person seeking help are understood.
NIDA identifies several clinical consequences of concealed substance use. A clinician may miss an opportunity to discuss interactions with prescribed medicines or screening for conditions associated with substance use. These can include HIV, hepatitis, and mental health conditions. This does not mean that every person needs every test. It means that relevant information helps clinicians make individualized decisions.
Disclosure alone does not remove bias. NIDA also reports that some healthcare professionals hold stigmatizing attitudes that can affect whether they provide evidence-based care. A dismissive response is therefore not always a misunderstanding that a patient can solve by explaining themselves more carefully. Responsibility for respectful assessment belongs with the healthcare system and its professionals, too.
Stigma may overlap with racism, sexism, and other discrimination. NIDA describes racial disparities in access to substance use treatment and medications for opioid use disorder. These overlapping barriers mean that people with similar health needs may encounter different obstacles. A single explanation focused on personal embarrassment cannot account for those differences.
Why can addiction stigma extend to medications and harm-reduction services?
Addiction stigma can attach to treatments and prevention services as well as to people. Medication may be dismissed as substituting one addiction for another, while harm reduction may be mistaken for approval of drug use. Ongoing recovery care and peer or therapy support have different roles from these medical and prevention tools.
NIDA describes medications as established treatments for some substance use disorders. Depending on the medication and condition, they can reduce withdrawal or cravings, or change the effects of substance use. Receiving prescribed treatment is not evidence that someone lacks commitment to recovery. Medication decisions belong within individualized medical care, rather than a moral ranking of recovery approaches.
Harm reduction addresses health risks associated with substance use. For example, NIDA describes syringe services programs as helping prevent infections and connect people with addiction treatment. It also explains that stigma can discourage participation and contribute to policy or funding barriers. Recognizing an immediate prevention need does not require pretending that substance use has no risks.
These services answer different questions: reducing a current health risk is different from treating a substance use disorder, although the two can connect. This general explanation does not establish that Choice provides syringe services or any particular medication. It also does not make one service a substitute for all other care.
Why does reducing addiction stigma require more than changing words?
Reducing addiction stigma requires respectful language, informed clinical care, and attention to rules or practices that limit access. A welcoming phrase does little if biased decisions continue. Clear personal boundaries can remain in place, while access to a care conversation should not depend on proving moral worth.
NIDA identifies education, language changes, and addressing systemic discrimination as connected responses. Education should include the fact that substance use disorders are treatable. It also needs to reach clinical decisions and access practices. Otherwise, an organization could replace a label while leaving the assumptions behind that label unchanged.
Meaningful changes can include:
- Describing behavior without reducing someone to a stereotype.
- Basing treatment decisions on clinical needs and evidence.
- Respecting self-description without imposing labels on others.
- Addressing racial, gender, and other overlapping discrimination.
- Recognizing treatment and prevention as legitimate healthcare needs.
Reducing stigma does not require denying harm, removing every boundary, or promising a judgment-free experience. It requires separating evidence from assumptions and evaluating people as individuals. A return to use can indicate a need to resume or modify treatment, according to NIDA's treatment and recovery guidance, rather than proving that the person is beyond help.
For immediate danger or suspected overdose, call 911. For a substance use or mental health crisis, call or text 988, as listed in NIDA's crisis resources.
Frequently asked questions about addiction stigma
Why is person-first language recommended when discussing addiction?
Person-first language identifies a health condition without making it someone's entire identity. Saying “a person with a substance use disorder” also avoids labels associated with blame. NIDA reports that wording can influence attitudes, including clinicians' judgments. Respectful language is a useful starting point, but it must be accompanied by appropriate care and fair treatment.
Can people in recovery choose different words to describe themselves?
Yes. People may choose language that reflects their experience, community, or recovery tradition. NIDA recognizes that some people use terms for themselves that would be inappropriate to impose on someone else. Respecting a chosen self-description does not mean assuming everyone shares it or using that label as a general description of people with addiction.
Can addiction stigma affect someone who uses drugs without a substance use disorder?
Yes. NIDA states that stigma also affects people who use drugs without having a substance use disorder. Others may make assumptions about their health, behavior, or character based on substance use alone. Describing what is known, rather than assigning a diagnosis or stereotype, helps distinguish substance use from a clinically assessed disorder.
Can fear of judgment make it harder to disclose substance use in healthcare?
Yes. Fear of bias or mistreatment can lead someone to conceal substance use or avoid care. NIDA explains that this can leave clinicians without information relevant to medication interactions, screening, and treatment. The response should include respectful clinical communication and appropriate assessment, rather than placing the entire burden of overcoming stigma on the patient.
Does understanding addiction as a medical condition mean ignoring harmful behavior?
No. Understanding impaired control helps explain why changing substance use can be difficult; it does not erase the effects of harmful actions. Specific behavior can still require boundaries, accountability, and repair. The distinction is between addressing what happened and treating a person as permanently bad or undeserving of evidence-based healthcare.
Sources
- National Institute on Drug Abuse: Stigma and Discrimination
- National Institute on Drug Abuse: Drugs and the Brain
- National Institute on Drug Abuse: Treatment
- National Institute on Drug Abuse: Treatment and Recovery
- Choice Recovery Path: Intensive Outpatient Program (IOP)
- Choice Recovery Path: Contact information and outpatient access
If outpatient support interests you, Choice's Intensive Outpatient Program (IOP) in Albuquerque, NM describes weekly group and individual therapy. You can use the Choice contact page to discuss current options without needing to know which service fits before reaching out.

